Medicare Enrolled

Dr. Tanya Kirpalani, PA-C

Chronic Disease Hospital · Clermont, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
17325 PAGONIA RD, Clermont, FL 34711
4079056000
In practice since 2011 (15 years)
NPI: 1982993143 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kirpalani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kirpalani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kirpalani

Dr. Tanya Kirpalani is a chronic disease hospital in Clermont, FL, with 15 years in practice. Based on federal Medicare data, Dr. Kirpalani performed 528 Medicare services across 437 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kirpalani received a total of $7,579 from 51 pharmaceutical and/or device companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in chronic disease hospital. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kirpalani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice▲ 528 Medicare services$ $7,579 industry payments

Medicare Practice Summary

Medicare Utilization ↗
528
Medicare services
1.0× state median for chronic disease hospital
437
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)225$66$339
Annual wellness visit, follow-up64$107$359
Office visit, established patient, complex (40-54 min)41$100$442
Drug injection, under skin or into muscle31$9$69
Office visit, established patient (20-29 min)30$44$241
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use24$280$719
Pneumonia vaccine administration24$30$76
Annual depression screening23$15$54
Flu vaccine administration21$30$76
Flu vaccine, high-dose19$71$129
Automated urinalysis13$2$10
Injection, methylprednisolone sodium succinate, up to 125 mg13$4$17
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,579
Total received (2021-2024)
Avg $1,895/year across 4 years
Top 0% in FL for chronic disease hospital
51
Companies
410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,492 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$87 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,916
2023
$1,870
2022
$2,094
2021
$1,699

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,003
AstraZeneca Pharmaceuticals LP
$850
ABBVIE INC.
$807
Lilly USA, LLC
$574
Abbott Laboratories
$406
Bayer Healthcare Pharmaceuticals Inc.
$395
Amgen Inc.
$374
Boehringer Ingelheim Pharmaceuticals, Inc.
$234
Janssen Pharmaceuticals, Inc
$225
AbbVie Inc.
$183
JAZZ PHARMACEUTICALS INC.
$174
PFIZER INC.
$169
Corium, LLC
$164
GlaxoSmithKline, LLC.
$150
SANOFI-AVENTIS U.S. LLC
$139
Astellas Pharma US Inc
$136
Kowa Pharmaceuticals America, Inc.
$122
Bayer HealthCare Pharmaceuticals Inc.
$114
Otsuka America Pharmaceutical, Inc.
$106
Exact Sciences Corporation
$106
Axsome Therapeutics, Inc.
$92
Novartis Pharmaceuticals Corporation
$73
Dynavax Technologies Corporation
$61
Tolmar, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Tris Pharma Inc
$56
Phadia US Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$48
Smith+Nephew, Inc.
$46
Merck Sharp & Dohme Corporation
$46
IDORSIA PHARMACEUTICALS US INC
$45
Biohaven Pharmaceuticals, Inc.
$44
SCILEX PHARMACEUTICALS INC.
$41
Clarus Therapeutics Inc.
$40
Daiichi Sankyo Inc.
$38
Phathom Pharmaceuticals, Inc.
$36
Teva Pharmaceuticals USA, Inc.
$32
Esperion Therapeutics, Inc.
$32
Dexcom, Inc.
$31
Antares Pharma, Inc.
$30
Acerus Pharmaceuticals Corporation
$26
Lundbeck LLC
$21
Scilex Pharmaceuticals Inc.
$19
Amarin Pharma Inc.
$19
SANOFI PASTEUR INC.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Merck Sharp & Dohme LLC
$15
Endo Pharmaceuticals Inc.
$14
Ironshore Pharmaceuticals Inc.
$13
Genentech USA, Inc.
$8
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · AREXVY · AZSTARYS · Aimovig · Azstarys · BELSOMRA · BREZTRI · CAPLYTA · COLLAGENASE SANTYL · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Dexcom G6 Transmitter · Dyanavel XR · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL 9 · Heplisav-B · INJECTAFER · ImmunoCAP · JARDIANCE · JATENZO · JORNAY PM · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · NASCOBAL · NEXLETOL · NUCALA · NURTEC ODT · Natesto · Otezla · Ozempic · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · SUNOSI · SYNJARDY · SYNTHROID · Saxenda · Sunosi · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZEPBOUND · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 0% for chronic disease hospital in FL.

Equivalent to $1,435 per 100 Medicare services performed
Looking for a chronic disease hospital in Clermont?
Compare chronic disease hospitals in the Clermont area by procedure volume, costs, and industry payment transparency.
Browse chronic disease hospitals nearby

Geographic Context

Chronic Disease Hospitals within 10 mi
1
Per 100K population
0.3
County median income
$69,956
Nearest hospital
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kirpalani is a clinical cardiology specialist, and high industry engagement (low-engagement, top 0%), with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kirpalani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kirpalani performed 225 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kirpalani receive payments from pharmaceutical companies?
Yes. Dr. Kirpalani received a total of $7,579 from 51 companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kirpalani's costs compare to other chronic disease hospitals in Clermont?
Dr. Kirpalani's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kirpalani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →